Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute

Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.

Article Attribution | Read More at Article Source